SCHEMBL21216997

SCHEMBL21216997

CCC1CN(C(C)C)CCC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25561753 0.85 DPP4 (0.33) —
SCHEMBL21145551 0.84 — —
SCHEMBL26170436 0.84 — —
SCHEMBL14038216 0.84 — —
SCHEMBL26170333 0.84 — —
SCHEMBL20289190 0.82 HRH3 (0.31) —
SCHEMBL4099991 0.81 — —
SCHEMBL22302281 0.80 — —
SCHEMBL21146199 0.78 GBA1 (0.33) —
SCHEMBL23426454 0.77 HRH3 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210040083-A1 GCN2 INHIBITORS AND USES THEREOF MERCK PATENT GMBH (DE) 2021-02-11 — — US disclosed
US-10793563-B2 GCN2 inhibitors and uses thereof MERCK PATENT GMBH (DE) 2020-10-06 — — US disclosed
US-20190233411-A1 GCN2 INHIBITORS AND USES THEREOF MERCK PATENT GMBH (DE) 2019-08-01 — — US disclosed
Send feedback